Status:
UNKNOWN
Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc
Lead Sponsor:
Hacettepe University
Conditions:
Glucocorticoids Toxicity
Rheumatoid Arthritis
Eligibility:
All Genders
18-80 years
Brief Summary
Hypothesis 1: A reduction in side effects is achieved with monitoring glucocorticoid treatment by using the Glucocorticoid Toxicity Index (GTI) in patients using glucocorticoids. Hypothesis 2: Monito...
Detailed Description
In this study, the side effects of glucocorticoids used by patients will be evaluated using the Glucocorticoid Toxicity Index (GTI) index. This index includes areas for commonly recognized adverse eve...
Eligibility Criteria
Inclusion
- 18 years and over
- Individuals who have received glucocorticoid treatment for RA, SLE or vasculitis in the last 2 years or at current admission.
- Patients approved by the physician to participate in the study
- Patients giving written consent
Exclusion
- Younger than 18
- Patients with communication disabilities
- Patients involved in another clinical and/or drug trial
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05292456
Start Date
February 1 2021
End Date
December 1 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye), 06100